Cambridge Trust’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $456K | Sell |
5,062
-1,387
| -22% | -$118K | 0.02% | 198 |
|
|
2023
Q4 | $514K | Buy |
6,449
+400
| +7% | +$30.1K | 0.02% | 188 |
|
|
2023
Q3 | $430K | Sell |
6,049
-377
| -6% | -$28.2K | 0.02% | 201 |
|
|
2023
Q2 | $495K | Sell |
6,426
-118
| -2% | -$9.13K | 0.02% | 189 |
|
|
2023
Q1 | $492K | Sell |
6,544
-352
| -5% | -$26.2K | 0.02% | 190 |
|
|
2022
Q4 | $544K | Buy |
6,896
+205
| +3% | +$15.4K | 0.02% | 188 |
|
|
2022
Q3 | $470K | Sell |
6,691
-693
| -9% | -$54.3K | 0.02% | 197 |
|
|
2022
Q2 | $591K | Buy |
7,384
+284
| +4% | +$22.2K | 0.03% | 187 |
|
|
2022
Q1 | $538K | Sell |
7,100
-1,039
| -13% | -$82.3K | 0.02% | 206 |
|
|
2021
Q4 | $695K | Buy |
8,139
+3,613
| +80% | +$282K | 0.02% | 193 |
|
|
2021
Q3 | $342K | Sell |
4,526
-1,041
| -19% | -$82.7K | 0.01% | 208 |
|
|
2021
Q2 | $453K | Sell |
5,567
-2,292
| -29% | -$187K | 0.02% | 182 |
|
|
2021
Q1 | $619K | Buy |
7,859
+3,258
| +71% | +$255K | 0.03% | 159 |
|
|
2020
Q4 | $393K | Sell |
4,601
-100
| -2% | -$8.27K | 0.02% | 168 |
|
|
2020
Q3 | $363K | Sell |
4,701
-1,062
| -18% | -$81K | 0.02% | 177 |
|
|
2020
Q2 | $442K | Sell |
5,763
-29
| -0.5% | -$2.06K | 0.02% | 163 |
|
|
2020
Q1 | $384K | Buy |
5,792
+1,201
| +26% | +$84.7K | 0.03% | 170 |
|
|
2019
Q4 | $316K | Buy |
4,591
+687
| +18% | +$46.8K | 0.02% | 221 |
|
|
2019
Q3 | $287K | Buy |
3,904
+200
| +5% | +$14.5K | 0.02% | 221 |
|
|
2019
Q2 | $265K | Buy |
+3,704
| New | +$263K | 0.02% | 223 |
|
|
2019
Q1 | – | Sell |
-4,004
| Closed | -$238K | – | 244 |
|
|
2018
Q4 | $238K | Hold |
4,004
| – | – | 0.02% | 220 |
|
|
2018
Q3 | $268K | Buy |
4,004
+265
| +7% | +$17.7K | 0.02% | 219 |
|
|
2018
Q2 | $242K | Buy |
3,739
+100
| +3% | +$6.54K | 0.02% | 227 |
|
|
2018
Q1 | $261K | Sell |
3,639
-810
| -18% | -$58.3K | 0.02% | 227 |
|
|
2017
Q4 | $336K | Sell |
4,449
-175
| -4% | -$12.8K | 0.02% | 213 |
|
|
2017
Q3 | $337K | Sell |
4,624
-271
| -6% | -$19.5K | 0.02% | 213 |
|
|
2017
Q2 | $363K | Sell |
4,895
-7,045
| -59% | -$523K | 0.03% | 204 |
|
|
2017
Q1 | $874K | Sell |
11,940
-3,510
| -23% | -$246K | 0.06% | 143 |
|
|
2016
Q4 | $1.01M | Buy |
15,450
+1,800
| +13% | +$123K | 0.07% | 129 |
|
|
2016
Q3 | $1.01M | Buy |
13,650
+1,520
| +13% | +$112K | 0.07% | 125 |
|
|
2016
Q2 | $888K | Buy |
12,130
+6,160
| +103% | +$439K | 0.07% | 133 |
|
|
2016
Q1 | $422K | Buy |
5,970
+55
| +0.9% | +$3.66K | 0.03% | 163 |
|
|
2015
Q4 | $394K | Buy |
5,915
+173
| +3% | +$11.5K | 0.03% | 161 |
|
|
2015
Q3 | $364K | Buy |
5,742
+1,295
| +29% | +$84.6K | 0.03% | 164 |
|
|
2015
Q2 | $291K | Sell |
4,447
-320
| -7% | -$21.7K | 0.02% | 177 |
|
|
2015
Q1 | $331K | Sell |
4,767
-1,305
| -21% | -$90.2K | 0.03% | 167 |
|
|
2014
Q4 | $420K | Buy |
6,072
+454
| +8% | +$30.7K | 0.04% | 150 |
|
|
2014
Q3 | $366K | Buy |
5,618
+830
| +17% | +$54.7K | 0.03% | 155 |
|
|
2014
Q2 | $327K | Buy |
4,788
+1,205
| +34% | +$80.8K | 0.03% | 161 |
|
|
2014
Q1 | $232K | Sell |
3,583
-441
| -11% | -$27.8K | 0.02% | 184 |
|
|
2013
Q4 | $262K | Sell |
4,024
-238
| -6% | -$15.2K | 0.02% | 171 |
|
|
2013
Q3 | $252K | Sell |
4,262
-100
| -2% | -$5.92K | 0.03% | 161 |
|
|
2013
Q2 | $250K | Buy |
+4,362
| New | +$259K | 0.03% | 160 |
|
Other funds holding CL
Cambridge Trust's CL Position: Q1 2024 in Review
Cambridge Trust reduced its Colgate-Palmolive (CL) stake by 22% in Q1 2024, selling an estimated $118K and leaving 5,062 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #198.
Cambridge Trust first reported a position in CL in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.01M in Q3 2016. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.
- Cambridge Trust held 5,062 shares of Colgate-Palmolive worth $456K as of Q1 2024.
- Cambridge Trust sold 1,387 Colgate-Palmolive shares in Q1 2024, an estimated $118K.
- Colgate-Palmolive made up 0.02% of Cambridge Trust's portfolio in Q1 2024, its #198 holding.
- Cambridge Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 43 quarters since.
- Cambridge Trust's Colgate-Palmolive position peaked at $1.01M in Q3 2016.
- 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.